Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer

Future Med Chem. 2013 Jun;5(9):991-4. doi: 10.4155/fmc.13.56.

Abstract

“In the search for novel approaches for the treatment of resistant cancers, small molecules targeting the cyclin dependent kinase inhibitors have shown considerable promise”

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Cell Cycle Checkpoints / drug effects
  • Cyclin-Dependent Kinase Inhibitor p21 / antagonists & inhibitors*
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Drug Resistance, Neoplasm
  • Humans
  • Kidney Neoplasms / drug therapy*
  • RNA Interference
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Small Molecule Libraries / chemistry*
  • Small Molecule Libraries / pharmacology
  • Small Molecule Libraries / therapeutic use

Substances

  • Antineoplastic Agents
  • Cyclin-Dependent Kinase Inhibitor p21
  • RNA, Small Interfering
  • Small Molecule Libraries